Silexan for treatment of anxiety and depression in the context of COVID-19

Research output: Journal article (peer-reviewed) › Letter/short communication

8 Citations (Scopus)

Original language	English
Pages (from-to)	47-48
Number of pages	2
Journal	European Neuropsychopharmacology
Volume	70
Early online date	23 Feb 2023
DOIs	https://doi.org/10.1016/j.euroneuro.2023.02.015
Publication status	Published - May 2023

Access to Document

@article{46cd2014a54b44e2b588001078af2579,

title = "Silexan for treatment of anxiety and depression in the context of COVID-19",

author = "Lucie Bartova and Markus Dold and Gernot Fugger and Ana Weidenauer and Dan Rujescu and Siegfried Kasper",

year = "2023",

month = may,

doi = "10.1016/j.euroneuro.2023.02.015",

language = "English",

volume = "70",

pages = "47--48",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Silexan for treatment of anxiety and depression in the context of COVID-19

AU - Bartova, Lucie

AU - Dold, Markus

AU - Fugger, Gernot

AU - Weidenauer, Ana

AU - Rujescu, Dan

AU - Kasper, Siegfried

PY - 2023/5

Y1 - 2023/5

UR - https://www.scopus.com/pages/publications/85149756841

U2 - 10.1016/j.euroneuro.2023.02.015

DO - 10.1016/j.euroneuro.2023.02.015

M3 - Letter/short communication

C2 - 36867894

SN - 0924-977X

VL - 70

SP - 47

EP - 48

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

ER -